The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Martin Unverdorben1, MD; Franz X. Kleber2, MD; Hubertus Heuer3, MD; Hans-Reiner Figulla4, MD; Christian Vallbracht5, MD; Matthias Leschke6, MD; Bodo Cremers7, MD; Stefan Hardt8, MD; Michael Buerke9, MD; Hanns Ackermann10, PhD; Michael Boxberger11, PhD ; Ralf Degenhardt1, PhD; Bruno Scheller7*, MD
1. Institut für Klinische Forschung, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Germany; 2. Klinik für Innere Medizin, Unfallkrankenhaus Berlin, Charité Universitätsmedizin, Berlin, Germany; 3. Medizinische Klinik, Kardiologie,
Aims: The one-year outcome of lesions in small coronary arteries by using a paclitaxel-iopromide-coated (3 µg/mm²) balloon catheter (DCB) has yielded good six-month angiographic and one-y